Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Octreotide acetate |
Is a |
False |
Octreotide |
Inferred relationship |
Some |
|
Octreotide adverse reaction |
Causative agent |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing octreotide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Allergy to octreotide |
Causative agent |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 50 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 100 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 500 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 200 µg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 10 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 20 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
octreotid 1 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide |
Inferred relationship |
Some |
|
Single photon emission computed tomography using radiolabeled octreotide (procedure) |
Using substance (attribute) |
False |
Octreotide |
Inferred relationship |
Some |
1 |
Single photon emission computed tomography using radiolabeled octreotide (procedure) |
Using substance (attribute) |
False |
Octreotide |
Inferred relationship |
Some |
1 |
Allergy to octreotide |
Causative agent |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Radiolabelled octreotide |
Is a |
False |
Octreotide |
Inferred relationship |
Some |
|
Indium (111-In) labelled octreotide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Octreotide |
Inferred relationship |
Some |
|
Octreotide acetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Octreotide |
Inferred relationship |
Some |
|
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 1 milligram/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing octreotide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Octreotide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing only octreotide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Octreotide (as octreotide acetate) 50 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Octreotide |
Inferred relationship |
Some |
1 |
Radiolabelled octreotide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Octreotide |
Inferred relationship |
Some |
|